BANK OF AMERICA CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BANK OF AMERICA CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.10B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $105.86B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $102.77B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $94.95B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $89.11B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $85.53B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $91.24B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $91.02B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $87.13B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $83.70B | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.51B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $26.97B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $26.31B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $27.53B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $31.98B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $17.89B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $27.43B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $28.15B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $18.23B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $17.82B | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.61B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($8.81B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $44.98B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($6.33B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($7.19B) | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $37.99B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $61.78B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $39.52B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $9.86B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $17.28B | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3,411.74B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3,261.30B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $3,180.15B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3,051.38B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $3,169.50B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2,819.63B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2,434.08B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2,354.51B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $2,281.23B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $2,188.07B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3,108.50B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2,967.34B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2,888.51B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2,778.18B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2,899.43B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2,546.70B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2,169.27B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2,089.18B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $2,014.09B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1,921.87B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $303.24B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $293.96B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $290.21B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $273.20B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $270.07B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $272.92B | Feb 20, 2024 |
| FY2022 | Dec 31, 2019 | $264.81B | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | $265.33B | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $267.15B | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $266.20B | Feb 19, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.02B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $69.02B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $69.02B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $69.02B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $69.02B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $68.95B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $68.95B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $68.95B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $68.95B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $68.97B | Feb 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $261.69B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $240.75B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $224.67B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $207.00B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $188.06B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $164.09B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $156.32B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $136.31B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $113.82B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $101.23B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $161.56B | Feb 19, 2020 |
| FY2018 | Dec 31, 2018 | $177.40B | Feb 26, 2019 |
| FY2017 | Dec 31, 2017 | $157.43B | Feb 22, 2018 |
| FY2016 | Dec 31, 2016 | $147.74B | Feb 23, 2017 |
| FY2015 | Dec 31, 2015 | $159.35B | Feb 24, 2016 |
| FY2014 | Dec 31, 2014 | $138.59B | Feb 25, 2015 |
| FY2013 | Dec 31, 2013 | $131.32B | Feb 25, 2014 |
| FY2012 | Dec 31, 2012 | $110.75B | Feb 28, 2013 |
| FY2011 | Dec 31, 2011 | $120.10B | Feb 23, 2012 |
| FY2011 | Dec 31, 2010 | $108.43B | Feb 23, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $317.82B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $283.28B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $302.20B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $275.98B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $280.12B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $262.93B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $240.86B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $229.39B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $227.40B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $216.82B | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.21B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 7.61B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 7.90B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 8.00B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 8.08B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 8.65B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 8.84B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 9.67B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 10.29B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 10.05B | Feb 22, 2018 |